Organism: Homo sapiens
Gene: 39890_at
Selected probe(set): 213657_s_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 39890_at (213657_s_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-4.0639505
Number of Samples:3 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, sarcomatoid; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma, sarcomatoid.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-3.547575
Number of Samples:2 / 3

Experimental	collecting duct carcinoma study 1
	Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC).
Control	normal kidney tissue (adult)
	Normal adult kidney tissue samples.

Relative Expression (log2-ratio):3.4489374
Number of Samples:4 / 2

Experimental	basal cell carcinoma study 3
	Primary tumor tissue from the eyelid of patients with basal cell carcinoma (BCC).
Control	normal epidermal keratinocytes
	Normal human epidermal keratinocytes (NHEK) (Kurabo Ind., Ltd., Osaka, Japan) cultured in HuMedia-KB2 medium at 37°C in humidified air containing 5% CO2.

Relative Expression (log2-ratio):-3.3108606
Number of Samples:2 / 3

Experimental	glioma study 16 (LN-319)
	Human glioma cell line LN319 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):-3.2914476
Number of Samples:2 / 3

Experimental	glioma study 16 (LN-18)
	Human glioma cell line LN018 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):-3.0646057
Number of Samples:22 / 4

Experimental	expO kidney cancer study 1 (papillary adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with papillary adenocarcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-3.064499
Number of Samples:5 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):2.8921986
Number of Samples:4 / 207

Experimental	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.
Control	expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with clear cell adenocarcinoma (NOS).

Relative Expression (log2-ratio):-2.754323
Number of Samples:2 / 3

Experimental	glioma study 16 (LN-229)
	Human glioma cell line LN229 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):-2.6722364
Number of Samples:3 / 4

Experimental	expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; metastatic)
	Metastatic tumor tissue obtained from a patient with primary clear cell adenocarcinoma (NOS) of the kidney.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.